Search results
Expert's warning over ‘world’s most infectious disease’ as cases soar in UK
Wales Online via Yahoo News UK· 3 days agoIf you haven't had it, do go along because there is a higher risk of getting measles at the moment."...
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
Zacks via Yahoo Finance UK· 3 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Health authorities are running out of time to control a new mpox strain in the DRC
Euronews via Yahoo News UK· 3 days agoBut there have been barriers to this approach in the DRC and broader region, given the stigma...
Health authorities are running out of time to control a new mpox strain in the DRC
EuroNews· 3 days agoA new strain of mpox that emerged in the Democratic Republic of the Congo (DRC) could become an...
Sun Life, Hang Seng expand services for rich clients, tout Hong Kong's family office push
South China Morning Post via Yahoo Finance UK· 4 days agoCanadian insurer Sun Life Financial and HSBC's subsidiary Hang Seng Bank are expanding their...
From 'latte makeup' to 'girl dinners,' TikTok has launched tons of trends. Will its influence last?
Associated Press Finance via Yahoo Finance UK· 4 days agoLess than six years later, the social media platform is deeply woven into the fabric of American...
GSK and CureVac to Restructure Collaboration into New Licensing Agreement (1)
PharmiWeb· 4 days agoLONDON, UK, TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 3, 2024 / GSK plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq:CVAC) today announced they have restructured their existing collaboration ...
Mammalian cell display with automated oligo design and library assembly allows for rapid residue...
Nature· 4 days agoUsing a new method for rapid, residue-level epitope determination combining flow cytometry and surface displayed alanine substitution variants the authors determined the epitopes of three new antibodies binding the SARS-CoV-2 Spike protein.
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline...
PharmiWeb· 4 days agoTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 3, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based ...
GSK to pay Curevac £1.2bn for full rights to develop and commercialise mRNA vaccines
CityAM via Yahoo Finance UK· 4 days agoUnder the new agreement, which covers mRNA vaccines used in the treatment of influenze and Covid-19,...